跳至主要内容
临床试验/NCT04080466
NCT04080466招募中2 期

Cam Type Femoroacetabular Impingement (FAI) is a Cause of Hip Pain in the Young Adult and a Precursor to Osteoarthritis (OA)

Ottawa Hospital Research Institute2 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2021年2月20日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
58
试验地点
2
主要终点
Assessment of [18F]-NaF as a biomarker of hip degeneration

研究概览

简要总结

An abnormally formed hip joint (cam deformity) is a major cause of osteoarthritis (OA). Individuals may not experience any symptoms until OA is severe due to extensive cartilage loss and changes in underlying bone. A series of studies showed that the cam deformity can lead to the development of OA if left untreated, thus strongly suggesting a causal relationship. Currently, the cam deformity that causes pain is surgically removed to relieve the pain and treat the associated cartilage damage. Recent studies have demonstrated that surgical treatment leads to bone and cartilage changes that were related to improved function and reduced pain.

详细描述

This study will allow the investigators to gain a better understanding of the relationship between cartilage and bone changes. The investigators will examine adult participants in the disease state that require surgical correction and compare to age-matched controls. The investigators will look at the impact of surgical intervention through joint-specific biomarkers of OA, specifically the PET-MRI and blood/urine biomarkers, which will allow them to simultaneously query cartilage and bone activity. The investigators propose that the use of PET-MRI will give more sensitive and hip-specific information about the joint health compared to the blood/urine biomarkers in patients with symptomatic cam morphology. Participants will undergo motion analysis and 3D modeling to help the investigators better understand the disease process during the performance of specific activities and define joint contact mechanics as they relate to the PET-MRI imaging, validating a biomarker for early joint degeneration. This diagnostic tool will be extremely useful for younger individuals with a cam deformity who have not yet developed symptoms. In the future the investigators could use this to detect early degeneration in adolescents to prevent and mitigate development of OA later on. This will also help the investigators develop activity guidelines for people with smaller cam deformities in order to avoid surgery and prevent degeneration.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Skeletally mature patient undergoing cam resection by hip arthroscopy with hip pain longer than 6 months
  • Absence of arthritis (Tonnis Grade 0 or 1)
  • Absence of dysplasia (LCEA > 25°) or overcoverage (LCEA > 39°)
  • Alpha angle greater than 55° on multiplanar imaging
  • Subject is over the age of 18 years old at time of enrollment
  • Subject is willing and able to complete required study visits and assessments
  • Subject is willing to sign the approved Informed Consent Form
  • Group 2 Inclusion Criteria:
  • Normal femoral head neck contour and no evidence of dysplasia
  • Subject is over the age of 18 years old at time of enrollment
  • Subject is willing and able to complete required study visits and assessments
  • Subject is willing to sign the approved Informed Consent Form

排除标准

  • Prior joint replacement surgery in any lower-limb joint due to OA
  • History of lower-limb joint or back injury in the last year that impairs mobility
  • Metallic prosthesis
  • Worked with metal, metal fragments in the eye
  • Blood transmittable disease(s)
  • In vivo devices (Aneurysm clip(s), Pacemaker, ICD, Implanted hearing device)
  • Extreme claustrophobia
  • Overweight or obese (BMI > 30) and/or waist circumference >102cm in men and >88cm in women
  • Diagnosis of Parkinson's or uncontrollable tremors
  • Known history of early OA in the immediate family
  • Pregnant, Breastfeeding, or planning to get pregnant
  • Cognitive impairment that prevents accurate completion of patient-reported outcome questionnaires
  • Patient unable/unwilling to complete all required follow-up visits
  • Participants who have been exposed to other sources of radiation within the last year (Bringing radiation exposure above annual maximum)

结局指标

主要结局

Assessment of [18F]-NaF as a biomarker of hip degeneration

时间窗: 24 months

This study will assess \[18F\]-NaF uptake in PET-MRI as a novel biomarker of hip degeneration. This will be done by evaluating the presence of active bone turnover.

次要结局

  • Change in N-terminal cross-linking telopeptide of type I collagen (NTX-1)(24 months)
  • Change in N-terminal pro-peptide of type I procollagen (PINP)(24 months)
  • Change in cartilage oligomeric matrix protein (COMP)(24 months)
  • Muscle Activity(24 months)
  • Change in iHot-33 score(24 months)
  • Change in EQ-5D-5L score(24 months)
  • Change in PET-MRI (SUV/T1Rho)(24 months)
  • qCT (Low Dose Computed Tomography)(Within 2 months after recruitment)
  • Change in C-reactive protein (CRP)(24 months)
  • Change in carboxy-terminal collagen crosslinks (CTx)(24 months)
  • Change in Hip Disability and Osteoarthritis Outcome Score (HOOS) score(24 months)
  • Joint Kinematics to predict hip contact forces(24 months)
  • Change in type II collagen telopeptide (CTX-II)(24 months)
  • Joint kinetics to predict hip contact forces(24 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Cam Type FAI is a Cause of Hip Pain in the Young... | 临床试验